kOFU, JAPAN–November 25, 2025–Researched by Industrial Info Resources (Sugar Land, Texas)–Industrial Info is tracking 426 active pharmaceutical and biotech projects in South Korea with a total investment value of US$10.7 billion. Among them, Lotte Biologics and Samsung Biologics Company Limited account for the largest investment in the contract development and manufacturing organization (CDMO) plants.
Source link
South Korea's Pharma-Biotech Companies to Invest US$10.7 Billion
Show Comments (0)
Hide Comments (0)
0
0
votes
Article Rating
Subscribe
Login
0 Comments
Oldest
Newest
Most Voted
Inline Feedbacks
View all comments
